MGNX (STOCKS)
MacroGenics, Inc.
$3.450000
-0.150000 (-4.17%)
Prev close: $3.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Risser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $221.17M
- Employees
- 341
- P/E (TTM)
- -3.04
- P/B (TTM)
- 4.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.23 | $-0.30 | +0.0664 | +22.40% |
|
Sep 2025 (Q3)
|
$0.27 | $-0.50 | +0.7715 | +153.84% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.62 | +0.0502 | +8.09% |
|
Mar 2025 (Q1)
|
$-0.65 | $-0.80 | +0.1475 | +18.50% |
Financial Statements
| Revenues | $149.50M |
| Benefits Costs and Expenses | $224.79M |
| Cost Of Revenue | $0.00 |
| Costs And Expenses | $222.34M |
| Operating Expenses | $222.34M |
| Research and Development | $147.17M |
| Other Operating Expenses | $75.17M |
| Operating Income/Loss | -$72.84M |
| Income/Loss From Continuing Operations After Tax | -$74.62M |
| Income/Loss From Continuing Operations Before Tax | -$75.29M |
| Income Tax Expense/Benefit | -$672.00K |
| Income Tax Expense/Benefit, Current | -$672.00K |
| Net Income/Loss | -$74.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$74.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Diluted Earnings Per Share | -$1.18 |
| Basic Average Shares | 63,155,096 |
| Diluted Average Shares | 63,155,096 |
| Assets | $256.85M |
| Current Assets | $219.94M |
| Inventory | $7.91M |
| Prepaid Expenses | $8.75M |
| Other Current Assets | $203.29M |
| Noncurrent Assets | $36.91M |
| Fixed Assets | $12.63M |
| Other Non-current Assets | $24.28M |
| Liabilities | $201.26M |
| Current Liabilities | $43.12M |
| Accounts Payable | $4.79M |
| Other Current Liabilities | $38.33M |
| Noncurrent Liabilities | $158.14M |
| Equity | $55.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $55.59M |
| Liabilities And Equity | $256.85M |
| Net Cash Flow From Operating Activities | -$81.04M |
| Net Cash Flow From Operating Activities, Continuing | -$81.04M |
| Net Cash Flow From Investing Activities | -$114.10M |
| Net Cash Flow From Investing Activities, Continuing | -$114.10M |
| Net Cash Flow From Financing Activities | $69.51M |
| Net Cash Flow From Financing Activities, Continuing | $69.51M |
| Net Cash Flow | -$125.62M |
| Net Cash Flow, Continuing | -$125.62M |
| Comprehensive Income/Loss | -$74.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$74.59M |
| Other Comprehensive Income/Loss | -$74.59M |